The NCCN Foundation has announced five recipients for this year’s Young Investigator Awards. The grantees come from National Comprehensive Cancer Network Member Institutions, and will each receive up to $150,000 in funding over a two-year period.
This marks the eighth year for the NCCN Foundation Young Investigator Awards supporting career development for innovative cancer researchers.
The 2018 awardees are:
Rebecca Arend, University of Alabama at Birmingham Comprehensive Cancer Center
The Role of TGF-β in Immune Suppression in Suboptimally Debulked Ovarian Cancer Patients
Yin Cao, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Disparities in Young-Onset Colorectal Cancer Survival According to Patient, Treatment, and Tumor Molecular Characteristics
Tim Luetkens, Huntsman Cancer Institute at the University of Utah
CD229 Chimeric Antigen Receptor T Cells for the Treatment of Multiple Myeloma
Edwin Manuel, City of Hope Comprehensive Cancer Center
Altering the Local Immune Landscape in Lung Cancer to Improve Anti-PD-1 Therapy
Cecilia Yeung, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Optimization of a Rapid Point of Care Device for Acute Promyelocytic Leukemia Diagnosis and Therapy Guidance
These five awardees were selected out of a pool of 48 applicants nominated from across the 27 NCCN member institutions. The NCCN Oncology Research Program will manage and oversee the projects for the next two years. The awardees will then present the results from their research at the NCCN 25th Annual Conference in 2020.
A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement.